Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Hundreds of millions of people worldwide await treatments for rare diseases.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.